© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
[2022] FWC 1594
Fair Work Commission
2022-06-22
Original judgment source is linked above.
s.394 - Unfair dismissal
Application for an unfair dismissal remedy - mandatory vaccination policy - refusal to be vaccinated against COVID-19 - lawful and reasonable direction - consultation - large organisation - Work Health and Safety Act 2011 (NSW) - Policy not invalid because of deficiencies in consultation - consultation deficiencies curable and cured prior to direction given under Policy - lawful and reasonable direction given - genuinely held fear of vaccine - no medical reason not to be vaccinated - valid reason for dismissal related to capacity or conduct - alternatives to dismissal - reasonable not to allow access to paid leave - dismissal not harsh, unjust or unreasonable - application dismissed.
3.1 All Employees are required to be fully vaccinated with an Approved COVID-19 Vaccine and provide the Company with Evidence of Vaccination within the timeframes set out in 3.4 below. The timeframes in 3.4 have been set in accordance with current general community accessibility and individual eligibility, as well as priority access for some aviation workers, and may be amended at the Company's discretion from time to time.
3.2 The Evidence of Vaccination must be provided by following the process set out in 6.1 below, unless the Company approves another process for the individual Employee ... The Company may request that an Employee provide further evidence if it is not satisfied with the Evidence of Vaccination they have provided.
3.3 The table in 3.4 below sets out the date by which Employees must be fully vaccinated with an Approved COVID-19 Vaccine and provide the Company with Evidence of Vaccination (Compliance Date). In limited circumstances where an Employee lives (or works) in a jurisdiction or location where an Approved COVID-19 Vaccine has not been available to them such that they cannot meet the relevant Compliance Date, they may be provided with reasonable additional time to be vaccinated against COVID-19. In these circumstances, the Compliance Date will be varied on the basis of the timing of Approved COVID-19 Vaccine availability in their jurisdiction or location. Employees will need to submit an application for a temporary exemption (including providing reasons for their request and relevant supporting documentation) via the exemption process in place at the relevant time, which will be notified to Employees.
3.5 Employees who are stood down will be required to be fully vaccinated with an Approved COVID-19 Vaccine and provide Evidence of Vaccination by the Compliance Date or their first duty, work day or shift, whichever is later.
3.9 Where an Employee wishes to seek a temporary or ongoing exemption (as applicable) from the requirement to be fully vaccinated with an Approved COVID-19 Vaccine by the Compliance Date or at all, they should do so no later than six (6) weeks prior to the Compliance Date applicable to the Employee. Please refer to Section 4 of this Policy for further information.
(a) Employees must comply with the requirements under this Policy to be fully vaccinated with an Approved COVID-19 Vaccine and provide Evidence of Vaccination.
(b) Employees who are unable to comply with the requirements of the Policy because of Medical Contraindications (or are seeking exemptions on other medical or non-medical grounds) should refer to section 4.
(c) Employees who do not comply with the requirements of the Policy (except those Employees granted an exemption under section 4) will be considered to have not complied with a lawful and reasonable direction. They may be subject to disciplinary action, which, in the circumstances, is likely to be termination of their employment.
(a) being fully vaccinated with an Approved COVID-19 Vaccine and providing Evidence of Vaccination on or before the Compliance Date;
(b) submitting an application for an exemption from the requirement under the Policy to be fully vaccinated with an Approved COVID-19 Vaccine within the timeframes and in the manner specified in section 4 of the Policy; and
(c) notifying their Manager or their HR representative if they are otherwise unwilling or unable to comply with the Policy by the Compliance Date or at all."
"Q: I am prepared to get vaccinated but would prefer to wait until I can get access to a Pfizer or Moderna vaccine. What should I do?
All Approved COVID-19 Vaccines currently available in Australia have been approved by the TGA and determined to be effective and safe for use as recommended by Government, and on the advice of a health practitioner.
The Government has advised that additional Pfizer and Moderna will be available soon and the Compliance Dates in the Policy have been based on current Government advice regarding the vaccination rollout, increased availability and the priority access given to aviation workers in most states and territories.
Q. My Compliance Date under the Policy is 15 November 2021. I would prefer to be vaccinated with the Novavax vaccine. Will I be able to wait until becomes available?
You will need to meet the Compliance Date of 15 November 2021, unless an exemption is granted. To date, the TGA has provisionally approved the Pfizer, AstraZeneca and Moderna vaccines. Pfizer Zeneca are currently available, and Moderna will start to become available from late 2021.
As at 20 September 2021, the Novavax vaccine has not been approved by the TGA nor endorsed by the WHO and is not available in Australia (or any other country). If Novavax is approved by the TGA, it is currently expected that the majority of doses won't start to become available until around January 2022 and it is not known who will have priority access to it."
Q: What will happen if I refuse to get vaccinated?
As with all workplace policies applying to Qantas Group employees, you will need to ensure you comply with the Policy.
The Company understands there may be a small number of people who may wish to seek an exemption, temporarily or on an ongoing basis, from the requirement to be fully vaccinated for medical or other reasons. Those cases will be assessed and managed on a case-by-case basis.
However, given the purpose and scope of the Policy, the Company expects that there will be very limited (if any) circumstances in which exemptions will be granted.
If you do not comply with the requirements under the Policy to be fully vaccinated with an Approved COVID-19 Vaccine and provide Evidence of Vaccination, and have not been granted an exemption, you will be considered to have not complied with a lawful and reasonable direction. If this happens, you may be subject to disciplinary action which, in the circumstances, is likely to be termination of your employment with the Company.
Q: I don't want to be vaccinated, is it an option to be redeployed to another role or do
Generally, no. The Policy applies to all Australia-based employees and all roles.
Can I apply for an exemption from the requirement under the Policy to be fully vaccinated?
Yes. The Company will consider requests for exemptions on a case by case basis. For more information on exemptions under the Policy, please refer to the Exemptions Q&A available on the Terminal and JEN.
Please note, given the purpose and scope of the Policy, the Company anticipates that very limited exemption applications will be accepted."
"• 89 per cent of those who responded are already partially or fully vaccinated against covid-19 or are planning to be...
"The Qantas Group will require all employees to be fully vaccinated against COVID-19 as part of the national carrier's commitment to safety.
Frontline employees - including cabin crew, pilots and airport workers - will need to be fully vaccinated by 15 November 2021 and the remainder of employees by 31 March 2022. There will be exemptions for those who are unable for documented medical reasons to be vaccinated, which is expected to be very rare.
The policy follows consultation with Qantas and Jetstar employees including a survey sent to 22,000 people to seek their views on vaccination...
It's clear that vaccinations are the only way to end the cycle of lockdowns and border closures and for a lot of Qantas and Jetstar employees that means getting back to work again. This was one of the largest responses to any survey we've conducted, even with thousands of our people stood down, which shows just how important this is for them.
Further discussions will take place with employees, their health and safety representatives and unions over the coming weeks on the detail of the policy, including how medical exemptions will be applied..."
"Firstly, thank you to everyone who took the time to fill out our recent COVID-19 vaccination survey. We had 12,000 responses from across Qantas, Jetstar, QantasLink, Freight, and Loyalty, with broad participation from both operational and corporate areas...
This feedback has strengthened our view that making COVID-19 vaccinations a requirement for all Qantas Group employees is the right decision.
... The survey showed that a small number of people don't want to or may be unable to be vaccinated. We'll manage requests for exemptions on a case-by-case basis, just as we do with existing policies.
And while we understand that some people won't agree with the new policy on principle, we have a responsibility to provide the safest environment for our people and customers that we reasonably can.
We have developed a proposed COVID-19 vaccination policy that covers all the detail and we'll be meeting with your health and safety representatives and unions to discuss the roll out.
Our plan is to roll out the vaccination requirement in two phases..."
a) at least 50 extraordinary consultation meetings specific to the proposed policy attended by management, employees and their health and safety representatives;
b) the promulgation of a risk assessment that had been prepared in relation to the Proposed Policy;
c) regular workplace health and safety committee meetings, which were a forum for feedback in relation to the Proposed Policy;
d) information sessions held by the Qantas Medical, Safety and People teams, at which employees could ask questions and provide feedback;
e) publication of a General COVID-19 Vaccinations Q&A document that was updated to address questions raised during the consultation process by employees, HSRs and unions;
f) the delivery of online "webinars" devoted to the proposed policy and where employees could ask questions and give feedback;
g) "Townhall" meetings hosted by members of Qantas Group's Group Management Committee, at which some of the Qantas Group's most senior executive managers spoke to the Proposed Policy, fielded employee questions and received feedback;
h) a separate mailbox was set up and monitored by a dedicated team of Qantas Group staff. Employees could send queries to this inbox and provide feedback on the Proposed Policy, which were responded to by the team; and
"... With respect to Sydney Line Maintenance in particular, this was a policy - proposed policy that was across the organisation considerate of the risk of COVID-19 and to the extent that Sydney Line Maintenance was deferred or postponed as suggested would have introduced other risk that is perceived or believed to be unnecessary and unreasonable, for example, the continuation of people working in an operational landscape in proximity to others that may or could have had contracted COVID-19 and a further delay could have introduced unnecessary risks to those individuals."
Medical Evidence in Support of the Vaccination Policy
"The TGA only grant provisional approval after a complete assessment of all available data is undertaken. The process applied by the TGA to COVID-19 vaccines is the same process taken by the TGA for any vaccine provisionally approved in Australia, and provisional approval is only granted if a vaccine is safe and effective. The TGA's evaluation process includes considering whether the need for early access to the vaccine, having regard to the seriousness of the COVID-19 pandemic, outweighs the risks of receiving the vaccine. The granting of provisional approval for the COVID-19 vaccines by the TGA indicates that the vaccine is safe and effective, and the risks of receiving the vaccine outweigh the risk posed by the consequences of contracting the virus. The TGA continue to monitor vaccine safety and efficacy after provisional approval is granted.
Accordingly, the advice from the Australian Government is that COVID-19 vaccines provisionally approved by the TGA are safe for use and effective in preventing transmission and the consequences of the virus. From the commencement of the vaccine roll out in Australia on 22 February 2021 up until 7 April 2022, over 57 million doses of COVID-19 vaccine have been administered. In that period, the TGA has found only 11 deaths were linked to immunisation and each of these deaths occurred after a person received the first dose of the AstraZeneca vaccine. In comparison to COVID-19, as at 9 April 2022, Australia-wide cases total approximately 5.02 million, and 6,550 deaths.
As with all medicines, people can experience adverse effects from receiving a COVID- 19 vaccine, however, serious adverse effects are very rare. For example, the risk of myocarditis after receiving a COVID-19 vaccination is approximately 2.3 per 100,000 vaccinated persons. Myocarditis is usually temporary and most people recover within a few days. To put this into perspective, the general population risk of myocarditis, without COVID-19 circulating the community, is approximately 9 cases per 100,000 of the population. Further, the risk of myocarditis from COVID-19 itself is approximately 156 cases per 100,000 COVID-19 cases.
As outlined above, an unvaccinated person is more at risk of being harmed by contracting the virus than receiving a COVID-19 vaccine when considering the number of COVID-19 cases in the community. Although a vaccinated person can still contract the virus, the protective benefits of receiving the COVID-19 vaccine far outweigh the potential risks of suffering serious health consequences and the likelihood of transmitting the virus to other persons. Whilst the option remains for unvaccinated individuals to await future vaccination, the risk of COVID-19 infection is high, and the rate of hospitalisation and death from COVID-19 remains relatively high."
Although other control measures, such as mask wearing, physical distancing, time minimisation, and sanitising, reduce the likelihood that someone will become infected with the virus, they do not provide a substitute for the protection afforded by vaccines against the severe health consequences a person can suffer from contracting the virus. Vaccination is the only practicable control available that has an effect on reducing the consequences of infection, whereas other control measures only affect the likelihood of becoming infected.
Since the beginning of the pandemic, aviation (including the Qantas Group's operations) have been considered a particular vulnerability for the potential movement of COVID-19 (i.e. from regions of higher prevalence to regions where COVID-19 was minimal to non-existent). Governments responded accordingly. This required the Qantas Group to engage with Federal and State Governments and Health Authorities to ensure that the various Public Health Orders, procedures and guidelines were followed."
Mr Tween's work history and response to the Vaccination Policy
"These matters all caused me to take unusually high amounts of sick leave across the second half of 2021. On bad days I knew I was unfit to make critical decisions that involved aircraft safety. I went sick on these days.
After Qantas announced that the policy was in place, I believed something would change. In my mind, I felt like I was living a bad dream and I would eventually wake, and things would return to normal."
"I could not sleep. I could not think straight. I genuinely feared for my life if I was forced to vaccinate."
"... I sincerely believe that the risk to me from the mRNA vaccines is too great ... In spite of all this I do still want to be vaccinated because I know the threat that Covid 19 poses.
I want the liberty to be able to wait until the NOVAVAX vaccine becomes available...
I am happy to declare that I am committed to getting the NOVAVAX vaccine.
I totally understand Qantas' position regarding the vaccination policy, due to the vast economic damage that Covid 19 has caused. I also sincerely apologise for not yet adhering to the policy. I was genuinely in a state of stress and anxiety in which I have never experienced before.
I therefore propose that if I am able to attend work I would only do so if I have evidence on my person of a negative Covid test within the previous three days (or less if you prefer) until such time as the NOVAVAX vaccine becomes available.
I have been a Qantas for almost 31 years. I love my job. It is the only job I have ever had. Until this year I have been the sole income earner for my family...
To lose my career now, especially over an issue of personal choice and health would be utterly devastating to me and to my family.
I hope that an agreement can be negotiated in regards to my employment with Qantas."
"This has been a very trying time. Stuart has been asked to take one of two vaccines. He is scared and suffering anxiety as a result. Stuart has advised Qantas that he is willing to be vaccinated. His preference is Novavax. Novavax does not scare him and will reduce his anxiety. Stuart can test each day prior to work and only attend if negative to Covid. As an alternative, he is prepared to take any form of leave until vaccinated with his preferred vaccine. We consider this approach reasonable. It is consistent with practices at other companies and comments made by the Fair Work Commission. Stuart is a long-standing employee with an unblemished record. His dismissal would have a devastating effect on his family."
"The Qantas Group strongly believes that vaccination against COVID-19 is critical for its people, customers, ongoing operations and for aviation more broadly. In addition to COVID- 19 vaccination regulatory requirements for airline workers, the Policy aims to provide the Group's employees and customers with consistency of protection against COVID-19 in company premises and other environments required for work. It is a reasonable additional control for Qantas Group employees against exposure to COVID-19 and limiting transmission from our employees to others. Vaccination is our best possible protection against the adverse impacts of COVID-19, including the potentially serious health consequences, on operational continuity and our business, and disruptions to the essential service we provide...
As at the date of this letter, the Novavax vaccine has not been approved by the Therapeutic Goods Administration (TGA) and is not available in Australia It is not currently known if and when Novavax will be approved by the TGA and, if it is, when it will become available and who will have initial access to it.
In your Written Response you suggested that you could undertake regular COVID-19 testing as an alternative to vaccination while you wait for Novavax, stating "I totally understand QANTAS' position regarding the vaccination policy ... I therefore propose that if I am able to attend work I would only do so if I have evidence on my person of a negative COVID 19 test within the previous three days (Or less if you prefer) until such time as the NOVAVAX Vaccine becomes available".
I have been informed that the Company does not consider that testing regimes alone are equivalent to vaccination as a control measure against the risks associated with COVID-19. While testing may detect the virus, it does not offer any protection from contracting the virus or any protection against the consequences of the virus which can include severe illness and hospitalisation. In contrast, vaccination protects against both these risks. Testing can at times not be 100% accurate or sensitive, so some cases can be missed, produce false negatives or fail to detect the virus in its early stages.
Further, reducing the risk of an unvaccinated worker contracting the virus would require frequent (at least daily) testing of not just the unvaccinated worker but also every person that worker comes into contact with in the workplace, in order to ensure (as far as possible, noting the inaccuracies associated with testing) that none of the unvaccinated worker's co-workers pass the virus on to the unvaccinated worker.
In these circumstances, the Company does not consider this a viable or satisfactory control measure against COVID-19."
(a) Qantas failed to consult relevant employees at all prior to deciding on 18 August 2021 to introduce the vaccine mandate; and
(b) the consultation that took place after the announcement of the policy (and before its terms were finalised and the Vaccination Policy commenced) was cursory at best, and deficient because Qantas did not answer all of the questions raised, and all of the requests made by SLM WHS Committee members; and
(c) consultation was deficient because Qantas failed to comply with the terms of the SLM WHS Committee Constitution.
Consultation prior to finalising the Vaccination Policy
SLM WHS Committee Constitution
"If the person conducting the business or undertaking and the workers have agreed to procedures for consultation, the consultation must be in accordance with those procedures."
"The method for WHS consultation at Sydney Line Maintenance (SLM) shall be through the above-mentioned committee, which has the authority to report directly to management."
The Committee will concern itself with safety-related matters that have been formally referred to the worker's immediate Supervisor and which have not been acted upon by way of rectification or advice."
"For the reasons set out above, we consider the direction to Mr Lee to submit to the collection of his fingerprint data, in circumstances where he did not consent to that collection, was not a lawful direction ... Given this finding, it is not necessary to consider whether the direction was reasonable. Nonetheless had it been necessary to do so we conclude the direction was unreasonable..."
"If a command relates to the subject matter of the employment and involves no illegality, the obligation of the servant to obey it depends at common law upon it being reasonable. In other words, the lawful commands of an employer which an employee must obey are those which fall within the scope of the contract of service and are reasonable."
"The effectiveness of the vaccines vary in relation to the Delta and Omicron variants of the virus. Vaccination affords a high degree of protection against transmission, hospitalisation and death from the Delta variant. The degree of effectiveness against transmission is generally lower with Omicron compared to Delta. As Omicron is a more transmissible variant than Delta, vaccination has a lesser effect on blocking transmission of the Omicron variant between persons, but vaccination still provides significant protection against hospitalisation and death from Omicron.
Vaccination against COVID-19 is the most effective and efficient control measure available to prevent the serious health consequences of the virus. Over the course of the Pandemic, unvaccinated adults, in comparison to vaccinated adults, have a higher risk of becoming infected with the virus, transmitting the virus and suffering serious health consequences, including death.
In a fully susceptible (unvaccinated and uninfected) population, one person with Delta would, on average, infect five other people, while one person with Omicron could transmit the virus to about 20 others. In comparison, vaccinations reduce onward transmission by approximately 45 to 65% for the Delta strain. Definitive data is still awaited for the Omicron strain, but early data suggests that vaccination is less effective in preventing onward transmission of Omicron.
A person who is vaccinated against COVID-19, in comparison to a person who is not vaccinated, among other things:
(a) is less likely to become infected with COVID-19, depending on the strain;
(b) is less likely to transmit COVID-19 to others, depending on the strain; and
(c) is substantially less likely to suffer serious health consequences, including death, for all known strains.
As a comparison of unvaccinated and vaccinated populations, the US data published as at 29 January 2022 demonstrated a death rate of 15.3 per 100,000 people for the unvaccinated, and a death rate of 2.3 per 100,000 for the fully vaccinated, as well as 0.7 per 100,000 for the boostered population. Local data for unvaccinated population compared with the vaccinated is not available."
(a) whether there was a valid reason for the dismissal related to the person's capacity or conduct (including its effect on the safety and welfare of other employees); and
(b) whether the person was notified of that reason; and
(c) whether the person was given an opportunity to respond to any reason related to the capacity or conduct of the person; and
(d) any unreasonable refusal by the employer to allow the person to have a support person present to assist at any discussions relating to dismissal; and
(e) if the dismissal related to unsatisfactory performance by the person - whether the person had been warned about that unsatisfactory performance before the dismissal; and
(f) the degree to which the size of the employer's enterprise would be likely to impact on the procedures followed in effecting the dismissal; and
(g) the degree to which the absence of dedicated human resource management specialists or expertise in the enterprise would be likely to impact on the procedures followed in effecting the dismissal; and
(h) any other matters that the FWC considers relevant.
Was there a valid reason for the dismissal related to the Applicant's capacity or conduct?
"The principles applicable to the consideration required under s 387(a) are well established, but they require reiteration here:
(1) A valid reason is one which is sound, defensible and well-founded, and not capricious, fanciful, spiteful or prejudiced.
(2) When the reason for termination is based on the misconduct of the employee the Commission must, if it is in issue in the proceedings, determine whether the conduct occurred and what it involved.
(3) A reason would be valid because the conduct occurred and it justified termination. There would not be a valid reason for termination because the conduct did not occur or it did occur but did not justify termination (because, for example, it involved a trivial misdemeanour).
(4) For the purposes of s 387(a) it is not necessary to demonstrate misconduct sufficiently serious to justify summary dismissal on the part of the employee in order to demonstrate that there was a valid reason for the employee's dismissal (although established misconduct of this nature would undoubtedly be sufficient to constitute a valid reason).
(5) Whether an employee's conduct amounted to misconduct serious enough to give rise to the right to summary dismissal under the terms of the employee's contract of employment is not relevant to the determination of whether there was a valid reason for dismissal pursuant to s 387(a).
(6) The existence of a valid reason to dismiss is not assessed by reference to a legal right to terminate a contract of employment.
(7) The criterion for a valid reason is not whether serious misconduct as defined in reg 1.07 has occurred, since reg 1.07 has no application to s 387(a).
(8) An assessment of the degree of seriousness of misconduct which is found to constitute a valid reason for dismissal for the purposes of s 387(a) will be a relevant matter under s 387(h). In that context the issue is whether dismissal was a proportionate response to the conduct in question.
(9) Matters raised in mitigation of misconduct which has been found to have occurred are not to be brought into account in relation to the specific consideration of valid reason under s 387(a) but rather under s 387(h) as part of the overall consideration of whether the dismissal is harsh, unjust or unreasonable."
(a) Firstly, the mandatory vaccination decision, and subsequent direction, was not lawful because Qantas failed to undertake the prescribed consultation required by NSW workplace health and safety legislation.
(b) Secondly, the way consultation was conducted was unreasonable.
(c) Thirdly, it was unreasonable to deny Mr Tween access to his accrued leave until his vaccination of choice was available.
(d) Fourthly, the dismissal was harsh considering his circumstances.
"It's uncontroversial that asking an employee to take COVID-19 vaccine is a major risk...It's a punt with excellent odds, overwhelmingly excellent odds but it is still asking employees to gamble with their lives to keep their jobs. Overwhelmingly excellent odds but it's a very personal decision for each individual and for some people it's a very difficult decision in the context of the height of vaccine paranoia, it's very challenging for people."
"You met with Mr Tween and Mr Gill on 13 January; you remember that? Yes, that's correct.
You were involved in a large number of these unvaccinated dismissals; is that right? Yes.
Were these termination meetings all happening at around the same time? They were happening at different points, I guess, because we were also dealing with some cases that were vaccinated late as well, so all happening consecutively but at different points as they were progressing.
When you told me earlier that you considered the question of whether Mr Tween should take leave, HR advised you that that wasn't appropriate; is that right? We considered it on - well, partly on an operational perspective and also as a group perspective. If people were allowed to take leave in engineering then people in other departments would also be allowed to take leave, so, operationally, it was considered it wasn't an option.
So just a blanket policy you're not allowed to take leave to wait for Novavax? Correct.
Mr Tween's particular personal circumstances, the amount of leave he had, his 30 years of perfect service, that didn't matter, there was an HR policy? As I said, it was definitely discussed, we did review it, but the decision was we needed a consistent approach across the business
So you are agreeing with me that there was a blanket policy? Correct."[13]
Is the Commission satisfied that the dismissal of the Applicant was harsh, unjust or unreasonable?
Mr R Dalton QC of Counsel with Mr M Garozzo of Counsel for the Respondent.
[1] (2021) 310 IR 399 at 458, [2021] FWCFB 6059 at [224].
[3] And that 4% are unwilling or unable to be vaccinated and 7% are undecided or unwilling to say.
[4] (2021) 310 IR 399 at 458, [2021] FWCFB 6059 at [224].
[5] (2019) 286 IR 368, [2019] FWCFB 2946 at [58] and [60].
[6] [1938] HCA 44; (1938) 60 CLR 601 at 621.
[7] (2021) 310 IR 399 at 426, [2021] FWCFB 6059 at [85].
[8] (2019) 286 IR 368, [2019] FWCFB 2946 at [25], [28],
[9] (2021) 310 IR 399 at 408, [2021] FWCFB 6059 at [15].
[10] [2021] FWC 6626 at [48]- [49]
[11] Citing Gelagotis v Esso Australia Pty Ltd [2018] FWCFB 6092 at [117]; Titan Plant Hire v Van Malsen [2016] FWCFB 5520, 263 IR 1 at [28]; Sharp v BCS Infrastructure Support Pty Limited [2015] FWCFB 1033 at [25]- [35].
[12] B, C and D v Australian Postal Corporation t/a Australia Post (2013) 238 IR 1, [2013] FWCFB 6191 at [36].
[13] Transcript, 19 May 2022 at [PN996] - [PN1002].
Printed by authority of the Commonwealth Government Printer
Stuart Tween
Qantas Airways Ltd [2022] FWC 1594
(2021) 310 IR 399
(2019) 286 IR 368
(1938) 60 CLR 601
(2013) 238 IR 1